|
PTK2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.206400E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.176900E-04 |
| Normal-vs-Stage2 |
9.295600E-01 |
| Normal-vs-Stage3 |
6.500600E-01 |
| Normal-vs-Stage4 |
5.957500E-02 |
| Stage1-vs-Stage2 |
4.067700E-02 |
| Stage1-vs-Stage3 |
1.339550E-02 |
| Stage1-vs-Stage4 |
7.22749999959582E-07 |
| Stage2-vs-Stage3 |
8.185400E-01 |
| Stage2-vs-Stage4 |
1.767180E-01 |
| Stage3-vs-Stage4 |
4.266000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.719700E-02 |
| Normal-vs-AfricanAmerican |
8.915400E-01 |
| Normal-vs-Asian |
2.266400E-01 |
| Caucasian-vs-AfricanAmerican |
2.333000E-01 |
| Caucasian-vs-Asian |
1.627010E-01 |
| AfricanAmerican-vs-Asian |
1.112650E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.447000E-01 |
| Normal-vs-Female |
1.255870E-02 |
| Male-vs-Female |
6.312400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.883950E-01 |
| Normal-vs-Age(41-60Yrs) |
1.087870E-02 |
| Normal-vs-Age(61-80Yrs) |
5.867200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.080000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.128200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.931570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.085840E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.754300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.302400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.906800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.441800E-03 |
| Normal-vs-Grade 2 |
2.4303999999975E-05 |
| Normal-vs-Grade 3 |
5.826000E-01 |
| Normal-vs-Grade 4 |
4.269800E-02 |
| Grade 1-vs-Grade 2 |
1.501220E-01 |
| Grade 1-vs-Grade 3 |
2.449000E-04 |
| Grade 1-vs-Grade 4 |
7.75299999999923E-05 |
| Grade 2-vs-Grade 3 |
2.53820000017946E-07 |
| Grade 2-vs-Grade 4 |
5.62380000013185E-07 |
| Grade 3-vs-Grade 4 |
8.364100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.55140000002163E-06 |
| Normal-vs-ccB subtype |
8.725000E-01 |
| ccA subtype-vs-ccB subtype |
2.00709999998994E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.361200E-01 |
| Normal-vs-N1 |
1.171590E-01 |
| N0-vs-N1 |
5.219600E-02 |
|
|
